SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001777
Filing Date
2009-03-16
Accepted
2009-03-16 17:30:34
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 PENWEST PHARMACEUTICALS CO. b73464ppe10vk.htm 10-K 1063718
2 EX-10.26 SUMMARY OF EXECUTIVE OFFICER BONUS PROGRAM b73464ppexv10w26.htm EX-10.26 1564
3 EX-10.27 SUMMARY OF THE DIRECTOR COMPENSATION PROGRAM b73464ppexv10w27.htm EX-10.27 6472
4 EX-10.34 FORM OF EXECUTIVE RETENTION AGREEMENTS b73464ppexv10w34.htm EX-10.34 55851
5 EX-23 CONSENT OF ERNST & YOUNG LLP b73464ppexv23.htm EX-23 3090
6 EX-31 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFIC b73464ppexv31.htm EX-31 8460
7 EX-32 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFIC b73464ppexv32.htm EX-32 2829
  Complete submission text file 0000950135-09-001777.txt   1143427
Mailing Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120
Business Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 877-736-9378
PENWEST PHARMACEUTICALS CO (Filer) CIK: 0001047188 (see all company filings)

IRS No.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23467 | Film No.: 09685642
SIC: 2834 Pharmaceutical Preparations